Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syed Rizvi

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Gene|October 29, 2011
Association of the ACE-II genotype with the risk of nephrotic syndrome in Pakistani childrenSaba Shahid, Aiysha Abid, Syed Qasim Mehdi, et al.
Sultan Qaboos University Medical Journal|May 3, 2014
Impaired Fasting Glucose in Omani Adults with no Family History of Type 2 DiabetesSawsan Al-Sinani, Mohammed Al-Shafaee, Ali Al-Mamari, et al.
Clinical Lymphoma & Myeloma|December 3, 2009
Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphomaMadeleine Duvic, Elise A Olsen, Debra Breneman, et al.
Leukemia Research|March 30, 2021
Corrigendum to "The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement" [Leukemia Res. 100 (2021) 106480]Colin P Bergstrom, Saurabh Dahiya, Weina Chen, et al.
Leukemia Research|December 7, 2020
The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvementColin P Bergstrom, Saurabh Dahiya, Weina Chen, et al.
World Journal of Diabetes|March 20, 2015
Association of gene variants with susceptibility to type 2 diabetes among OmanisSawsan Al-Sinani, Nicolas Woodhouse, Ali Al-Mamari, et al.
Leukemia & Lymphoma|January 14, 2012
Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibitionReinhard Dummer, Marc Beyer, Kenneth Hymes, et al.
Pharmaceutics|December 23, 2023
Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor MicroenvironmentVidhi M Shah, Syed Rizvi, Alexander Smith, et al.
Future Oncology (London, England)|April 7, 2020
ENGINE: a Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic biomarker DGM1Grzegorz S Nowakowski, Jun Zhu, Qingyuan Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 studyAtsushi Ohtsu, Jaffer A Ajani, Yu-Xian Bai, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Gene|October 29, 2011
Association of the ACE-II genotype with the risk of nephrotic syndrome in Pakistani childrenSaba Shahid, Aiysha Abid, Syed Qasim Mehdi, et al.
Sultan Qaboos University Medical Journal|May 3, 2014
Impaired Fasting Glucose in Omani Adults with no Family History of Type 2 DiabetesSawsan Al-Sinani, Mohammed Al-Shafaee, Ali Al-Mamari, et al.
Clinical Lymphoma & Myeloma|December 3, 2009
Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphomaMadeleine Duvic, Elise A Olsen, Debra Breneman, et al.
Leukemia Research|March 30, 2021
Corrigendum to "The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement" [Leukemia Res. 100 (2021) 106480]Colin P Bergstrom, Saurabh Dahiya, Weina Chen, et al.
Leukemia Research|December 7, 2020
The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvementColin P Bergstrom, Saurabh Dahiya, Weina Chen, et al.
World Journal of Diabetes|March 20, 2015
Association of gene variants with susceptibility to type 2 diabetes among OmanisSawsan Al-Sinani, Nicolas Woodhouse, Ali Al-Mamari, et al.
Leukemia & Lymphoma|January 14, 2012
Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibitionReinhard Dummer, Marc Beyer, Kenneth Hymes, et al.
Pharmaceutics|December 23, 2023
Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor MicroenvironmentVidhi M Shah, Syed Rizvi, Alexander Smith, et al.
Future Oncology (London, England)|April 7, 2020
ENGINE: a Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic biomarker DGM1Grzegorz S Nowakowski, Jun Zhu, Qingyuan Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 studyAtsushi Ohtsu, Jaffer A Ajani, Yu-Xian Bai, et al.
Pageof 12